The Effectiveness of a Customized Mobile Application in Colonoscopy Preparation

December 28, 2015 updated by: Ala'a Sharara, American University of Beirut Medical Center

The Effectiveness of a Customized Mobile Application in Colonoscopy Preparation: A Randomized Controlled Trial

Colonoscopy is the preferred procedure to investigate any large-bowel disease in adults and children. In addition, colonoscopy is the current gold standard for colorectal cancer screening due to its high diagnostic capabilities and its unique feature that permits sampling and removal of pathology. For optimal performance and visualization of details, however, an adequate bowel preparation is essential. Inadequate bowel preparation is associated with cancelled procedures, prolonged procedure time, incomplete examination, increased cost and possibly complications, physician frustration and patient anxiety, but most importantly serving to impede colorectal cancer screening and surveillance.

A good bowel preparation would need a solution with a reasonable volume, acceptable taste, minimal diet restrictions, and easy to follow instructions; and would also need patients' adherence to the instructions and diet restrictions. Noncompliance of patients to the diet restrictions, the starting day of diet, the timing of drinking the solution, and other instructions play an important role in rendering the colon preparation inadequate.

Aim: The investigators aim, at assessing the influence of having a reminder mobile application on the compliance and adherence to instructions and diet and consequently on the quality of colon preparation.

Hypothesis: The investigators' hypothesis is that patients having a customized mobile App reminding them systematically about instruction and time of intake of the preparation will have a better adherence to the prep protocol and likely on the quality preparation than those given written and verbal instructions in clinic.

Study Overview

Detailed Description

This is a randomized controlled trial that will include patients undergoing elective colonoscopy at the American University of Beirut Medical Center. Patients will be randomized into one of two study arms using a computer generated randomization list. 160 patients will be enrolled in total. All patients will be instructed by the study coordinator on the importance of adherence to the protocol in the leaflet emphasizing its importance to the colonoscopy quality. In addition, patients in Arm 2 will be given information about the application features. The application will have push notifications to inform patient on time of start of dietary changes, type of diet, time of preparing the solution, time of drinking the solution, reminder of their appointment, etc. All patients will then be interviewed by the research coordinator to evaluate the adherence to the assigned diet and compliance with the prep protocol as the main outcome and the ease of the application and the patient's attitude towards having such application as secondary outcomes. Based on the results of similar studies that assessed the use of software system to improve compliance, the investigators' sample size was a calculated assuming similar results. Calculations showed that 78 patients per arm will be enough to attain significance. The number 80 was chosen as attrition is presumed to be low. As for the statistical analysis, SPSS version 20.0 will be used for data entry and analysis.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beirut, Lebanon
        • American University of Beirut Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elective outpatient colonoscopy
  • Consent to the study
  • Owning a smartphone

Exclusion Criteria:

  • Pregnant or lactating women
  • Age less than 18 years
  • Known Inflammatory bowel disease
  • Significant gastroparesis
  • Gastric outlet obstruction
  • Ileus
  • Known or suspected bowel obstruction or perforation
  • Phenylketonuria
  • Toxic colitis or megacolon
  • Having a stoma
  • Compromised swallowing reflex or mental status
  • Psychiatric disease or known or suspected poor compliance
  • Severe chronic renal failure (creatinine clearance <30 mL/minute)
  • Severe congestive heart failure (New York Heart Association [NYHA] class III or IV)
  • Dehydration
  • Laxative use or dependency
  • Chronic constipation (<3 spontaneous bm/week)
  • Uncontrolled hypertension (systolic blood pressure ≥170 mm Hg, diastolic blood pressure ≥100 mm Hg)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Instruction leaflet
Patients will receive the Picoprep solution with an instruction leaflet of how to use it and the dietary modifications needed
Patients will receive the Picoprep solution with an instruction leaflet of how to use it and the dietary modifications needed
The research fellow will explain instructions to patients
Experimental: Mobile App
Patients will receive Picoprep solution with an instruction leaflet + Picoprep Mobile App which will be downloaded to their smartphones that has the same information plus a reminder utility
Patients will receive the Picoprep solution with an instruction leaflet of how to use it and the dietary modifications needed
The research fellow will explain instructions to patients
Patients will receive Picoprep solution with an instruction leaflet + Picoprep Mobile App which will be downloaded to their smartphones that has the same information plus a reminder utility

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of the preparation using the modified Aronshick scale
Time Frame: Directly after the Colonoscopy
During every colonoscopy a blinded interventionalist will assess the quality of the preparation using the modified Aronshick scale
Directly after the Colonoscopy
Questionnaire for adherence to the assigned diet
Time Frame: 30 minutes before the Colonoscopy
The research coordinator will ask the patients specific questions to assess their adherence to the assigned diet ( first and second dietary changes)
30 minutes before the Colonoscopy
Questionnaire for compliance with the prep protocol
Time Frame: 30 minutes before the Colonoscopy
The research coordinator will ask the patients specific questions to assess their compliance with the prep protocol
30 minutes before the Colonoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction with the written instructions and mobile application using a visual analogue scale
Time Frame: 30 minutes before the Colonoscopy
Patient satisfaction will be assessed using a visual analogue scale
30 minutes before the Colonoscopy
Questionnaire for ease of use of the mobile App
Time Frame: 30 minutes before the Colonoscopy
Patients will be asked about the ease of use of the mobile App
30 minutes before the Colonoscopy
Questionnaire for patient willingness to take the same preparation in the future if needed
Time Frame: 30 minutes before the Colonoscopy
Patients will be asked about their willingness to take the same preparation in the future if needed
30 minutes before the Colonoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ala' I Sharara, MD, American University of Beirut Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

July 10, 2013

First Submitted That Met QC Criteria

April 7, 2015

First Posted (Estimate)

April 8, 2015

Study Record Updates

Last Update Posted (Estimate)

December 29, 2015

Last Update Submitted That Met QC Criteria

December 28, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonoscopy Preparation

Clinical Trials on Instruction leaflet

3
Subscribe